Avanos Medical, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Avanos Medical (NYSE: AVNS) announced that CEO Dave Pacitti will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, Jan. 13, 2026 at approximately 2:15 p.m. PST. A live webcast will be available on the company Investors website and the presentation will be archived there for later viewing.

News Market Reaction – AVNS

+4.79%

+4.79% Session close to close

In the Jan 8 session, AVNS gained 4.79%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights Avanos’s participation in a major healthcare investor conference, with ...

Analysis

This announcement highlights Avanos’s participation in a major healthcare investor conference, with management presenting on Jan 13, 2026. In recent months, the company has reported Q3 2025 losses, executed acquisitions and divestitures, and undertaken restructuring with executive changes. Investors may watch for any updated commentary on these initiatives and financial trends during the presentation, as well as how management frames progress on cost savings and portfolio strategy.

Key Figures

Conference edition: 44th Presentation date: Jan 13, 2026 Presentation time: 2:15 p.m. PST

3 metrics

Conference edition 44th 44th Annual J.P. Morgan Healthcare Conference

Presentation date Jan 13, 2026 Scheduled presentation at J.P. Morgan Healthcare Conference

Presentation time 2:15 p.m. PST Scheduled start time of conference presentation

Historical Context

5 past events · Latest: Nov 05 (Negative)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Nov 05	Q3 2025 earnings	Negative	-5.7%	Q3 net loss and weaker profitability despite modest sales growth and guidance update.
Oct 27	Earnings call notice	Neutral	-0.8%	Announcement of webcast details for upcoming Q3 2025 earnings discussion.
Oct 23	Business divestiture	Neutral	-0.3%	Agreement to sell US Game Ready orthopedic rental business with supply agreement.
Sep 15	Nexus acquisition	Positive	+0.4%	Acquisition of Nexus Medical to strengthen critical care nutrition and medication delivery.
Aug 05	Management changes	Neutral	-12.1%	CFO appointment and CEO joining board accompanied by a sharp share price drop.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent news has often coincided with downside moves, especially around earnings and restructuring, with only the Nexus Medical acquisition showing a modest positive reaction.

Recent Company History

Over the last six months, Avanos reported Q3 2025 results on Nov 5, 2025 with higher sales but a net loss, and the stock fell 5.66%. A prior call announcement on Oct 27, 2025 and two portfolio transactions (including the Nexus Medical acquisition and a Game Ready® business divestiture) produced muted price changes, with only a 0.41% uptick on the Nexus deal. Management changes on Aug 5, 2025 coincided with a 12.09% drop. Today’s conference appearance fits a pattern of active strategic communication amid restructuring.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ALPHARETTA, Ga., Jan. 7, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Dave Pacitti, chief executive officer, will present at the 44^th Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Tuesday, Jan. 13, at approximately 2:15 p.m. PST.

A webcast of the conference presentation will be available on the Investors section of the Avanos Medical website and will be archived on that site.

About Avanos Medical, Inc. 
Avanos Medical, Inc. (NYSE: AVNS) is a medical technology company focused on delivering clinically superior medical device solutions that will help patients get back to the things that matter. Headquartered in Alpharetta, Georgia, we are committed to addressing some of today's most important healthcare needs, including providing a vital lifeline for nutrition to patients from hospital to home, and reducing the use of opioids while helping patients move from surgery to recovery. We develop, manufacture and market our recognized brands globally and hold leading market positions in multiple categories across our portfolio. For more information, visit www.avanos.com and follow Avanos Medical on X (@AvanosMedical), LinkedIn and Facebook.

View original content to download multimedia:https://www.prnewswire.com/news-releases/avanos-medical-inc-to-present-at-the-44th-annual-jp-morgan-healthcare-conference-302655855.html

SOURCE Avanos Medical

FAQ

When will Avanos Medical (AVNS) present at the J.P. Morgan Healthcare Conference?

Avanos Medical (AVNS) will present on Tuesday, Jan. 13, 2026 at approximately 2:15 p.m. PST.

Who from Avanos Medical (AVNS) is presenting at the Jan. 13, 2026 conference?

Chief executive officer Dave Pacitti will deliver the presentation for Avanos Medical (AVNS).

How can investors watch Avanos Medical (AVNS) presentation at the J.P. Morgan conference?

A live webcast will be available on the company's Investors website, and the presentation will be archived there after the event.

Will the Avanos Medical (AVNS) J.P. Morgan presentation be available after the event?

Yes. The presentation will be archived on the Avanos Medical Investors website for later viewing.